FDA-authorized software as a medical device in mental health: a perspective on evidence, device lineage, and regulatory challenges.
PMID: 41298848 ·
J, u, l, i, a, n, , H, e, r, p, e, r, t, z, ;, , A, r, i, e, l, , D, , S, t, e, r, n, ;, , N, i, l, s, , O, p, e, l, ;, , U, l, r, i, c, h, , R, e, i, n, i, n, g, h, a, u, s, ;, , J, o, h, n, , T, o, r, o, u, s
Anzeige
Zusammenfassung
FDA approval is widely regarded as a benchmark of quality for medical devices. However, concerns persist regarding its regulatory framework for digital mental health devices. This perspective article examined FDA-authorized Software as a Medical Device (SaMD) in mental health, tracing the devices' regulatory lineage through the De Novo and 510(k)-clearance pathways while assessing the quality of evidence that led to their authorization. Many 510(k)-cleared devices lacked direct evidence of effec
Anzeige
Offizielle Quelle
Auf PubMed ansehen →Daten aus PubMed / NCBI. Den Volltext und die aktuellsten Informationen finden Sie stets im offiziellen Eintrag.